Soligenix(SNGX)
$0.32+0.00 (+0.31%)
SNGX
Soligenix stock drug pipeline
$0.32
At close:+0.00 (+0.31%)
Want to see SNGX full AI Analyst Report?
Soligenix (SNGX) Drug Pipeline
786 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Hypericin | Cutaneous T Cell Lymphoma, Mycosis Fungoides, Ctcl/ Mycosis Fungoides, Ctcl | Phase III | Recruiting | Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL | Jun 17, 2024 | ― |
| Dusquetide | Behçet Disease | Phase II | Completed | Dusquetide for the Treatment of Behcet's Disease | Apr 23, 2024 | ― |
| Hypericin, Mechlorethamine Topical Gel | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Phase II | Completed | HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL | Nov 20, 2023 | ― |
| Hypericin | Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris | Phase II | Recruiting | Topical SGX302 for Mild-to-Moderate Psoriasis | Jun 28, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Hypericin | Phase III | Cutaneous T Cell Lymphoma, Mycosis Fungoides, Ctcl/ Mycosis Fungoides, Ctcl | Recruiting | Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL | Jun 17, 2024 | ― |
| Dusquetide | Phase II | Behçet Disease | Completed | Dusquetide for the Treatment of Behcet's Disease | Apr 23, 2024 | ― |
| Hypericin, Mechlorethamine Topical Gel | Phase II | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Completed | HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL | Nov 20, 2023 | ― |
| Hypericin | Phase II | Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris | Recruiting | Topical SGX302 for Mild-to-Moderate Psoriasis | Jun 28, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Soligenix Inc (SNGX) have in its pipeline
Soligenix SNGX is currently developing the following drugs: Hypericin, Dusquetide, Hypericin, Mechlorethamine Topical Gel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

